FUJIFILM Cellular Dynamics, Inc. - Jun 17, 2021 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
10%+ Owner
Signature
/s/ Takeshi Yamamoto, President and CEO of FUJIFILM Cellular Dynamics, Inc. and attorney-in-fact for FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation
Stock symbol
IPSC
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
3
Date filed
6/17/2021, 05:28 PM
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IPSC Common Stock 2.98M Jun 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IPSC Series A Convertible Preferred Stock Jun 17, 2021 Common Stock 3.97M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly.
F2 FUJIFILM Cellular Dynamics, Inc. holds 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock is immediately convertible into shares of the issuer's common stock and has no expiration date. The 10,000,000 shares of Series A Convertible Preferred Stock will be automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering.

Remarks:

Exhibit List: Exhibit 24 - Joint Filing Agreement and Power of Attorney Exhibit 99 - Joint Filer Information